TY - JOUR
T1 - Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)
AU - Mahedi, Md Rezwan Ahmed
AU - Rawat, Anurag
AU - Rabbi, Fazle
AU - Babu, K. Suresh
AU - Salvador Tasayco, Elias
AU - Areche, Franklin Ore
AU - Pacovilca-Alejo, Olga Vicentina
AU - Flores, Denis Dante Corilla
AU - Aguilar, Salomón Vivanco
AU - Orosco, Fredmoore L.
AU - Syrmos, Nikolaos
AU - Mudhafar, Mustafa
AU - Afrin, Sadia
AU - Rahman, Mst Mahfuza
N1 - Publisher Copyright:
© RJPT All right reserved.
PY - 2023/8
Y1 - 2023/8
N2 - Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.
AB - Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.
KW - Bangladesh, etc
KW - Bats
KW - Encephalitis
KW - Molecular Epidemiology
KW - Nipah virus (NIV)
KW - Pathogenicity
KW - Respiratory system
UR - https://www.scopus.com/pages/publications/85178963706
U2 - 10.52711/0974-360X.2023.00592
DO - 10.52711/0974-360X.2023.00592
M3 - Artículo
AN - SCOPUS:85178963706
SN - 0974-3618
VL - 16
SP - 3588
EP - 3594
JO - Research Journal of Pharmacy and Technology
JF - Research Journal of Pharmacy and Technology
IS - 8
ER -